Nabiximols in Multiple Sclerosis: Beyond Spasticity-An Exploratory Systematic Review and Meta-Analysis of Symptomatic Outcomes.

Kleiner D, Horváth IL, Mátis D, Nagy R, Gergő D, Lugosi K, Fazekas G, Fehérvári P, Hegyi P, Csupor D

Open source

DOI
10.3390/medsci14030346
Published
2026 Jun 25
Container
Medical sciences (Basel, Switzerland)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/medsci14030346,
  title = {Nabiximols in Multiple Sclerosis: Beyond Spasticity-An Exploratory Systematic Review and Meta-Analysis of Symptomatic Outcomes.},
  author = {Kleiner D and Horváth IL and Mátis D and Nagy R and Gergő D and Lugosi K and Fazekas G and Fehérvári P and Hegyi P and Csupor D},
  year = {2026},
  journal = {Medical sciences (Basel, Switzerland)},
  doi = {10.3390/medsci14030346},
  url = {https://doi.org/10.3390/medsci14030346}
}

RIS

TY  - JOUR
TI  - Nabiximols in Multiple Sclerosis: Beyond Spasticity-An Exploratory Systematic Review and Meta-Analysis of Symptomatic Outcomes.
AU  - Kleiner D
AU  - Horváth IL
AU  - Mátis D
AU  - Nagy R
AU  - Gergő D
AU  - Lugosi K
AU  - Fazekas G
AU  - Fehérvári P
AU  - Hegyi P
AU  - Csupor D
PY  - 2026
JO  - Medical sciences (Basel, Switzerland)
DO  - 10.3390/medsci14030346
UR  - https://doi.org/10.3390/medsci14030346
ER  - 

APA

D, K., IL, H., D, M., R, N., D, G., K, L., G, F., P, F., P, H., & D, C. (2026). Nabiximols in Multiple Sclerosis: Beyond Spasticity-An Exploratory Systematic Review and Meta-Analysis of Symptomatic Outcomes.. Medical sciences (Basel, Switzerland). https://doi.org/10.3390/medsci14030346

Source records